The use of robotics in pharmaceutical manufacturing to peak in three to five years: Poll
The COVID-19 pandemic, however, might have given the industry the much-needed push to increase the adoption of robotics to ensure…
27 Jul 2021
Adagio and Biocon collaborate to develop antibody therapy for Covid-19
Adagio Therapeutics has signed a collaboration agreement granting an exclusive licence to Biocon Biologics for producing and marketing a Covid-19 antibody therapy based on ADG20. A potent, long-acting neutralising monoclonal antibody,…
26 Jul 2021
US acquires 200 million more doses of Pfizer-BioNTech’s Covid-19 vaccine
The US Government has bought an additional 200 million doses of Pfizer and BioNTech’s Covid-19 vaccine for meeting the continued requirement for jabs in the country. The vaccine is authorised…
26 Jul 2021
EMA committee recommends Moderna’s Covid-19 vaccine for adolescents
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion on the marketing authorisation of the Moderna Covid-19 vaccine, Spikevax, for adolescents…
23 Jul 2021
Innovation’s drug shows antiviral activity against Covid-19 in study
Innovation Pharmaceuticals has reported that its drug candidate, Brilacidin, showed broad-spectrum antiviral activity against Covid-19 in an in vitro study. A non-peptidic defensin-mimetic drug, Brilacidin is presently being analysed in…
22 Jul 2021
Johnson & Johnson reports 27.1% increase in Q2 2021 sales
Johnson & Johnson (J&J) has reported sales of $23.31bn in the second quarter (Q2) of 2021, an increase of 27.1% compared to $18.33bn in the same quarter last year. Net…
22 Jul 2021
Pfizer and Biovac partner to produce Covid-19 vaccine in Africa
Pfizer and BioNTech have signed a letter of intent (LoI) with South African biopharmaceutical company, The Biovac Institute, to produce their Covid-19 vaccine for supply in the African Union. The…
© Copyright Verdict Media Limited 2021
Powered by
